Product Detail

VIRILOZOL (Stanozolol USP) Tablets

API :

CAS NO : 10418-03-8

Usage :

• Introduction

VIRILOZOL contains Stanozolol USP, a synthetic anabolic steroid derived from dihydrotestosterone (DHT). Available in 5 mg, 10 mg, and 20 mg tablet forms, it is widely recognized for its strength-enhancing and muscle-hardening effects, with minimal androgenic and no estrogenic activity.

Medically, Stanozolol has been used to treat anemia and hereditary angioedema, but it is more popular in sports and bodybuilding for enhancing definition, vascularity, and dry muscle gains.

• Benefits

• Promotes lean, dry muscle mass
• Enhances vascularity and muscle definition
• Increases strength and speed without significant weight gain
• No estrogenic conversion — no risk of gynecomastia
• Ideal for cutting cycles, pre-contest prep, and recomposition
• Mild anabolic profile, suitable for some female users (with caution)

• Dosage Guide

Performance Use by Experience Level:

User Level           Daily Dosage    Cycle Duration

Beginner              20–30 mg          6–8 weeks

Intermediate      40–50 mg          6–8 weeks

Advanced            50–70 mg          6–8 weeks (with liver support)

💊 Dosage can be split into 2–3 servings per day to maintain stable blood levels.
Often stacked with non-aromatizing injectables like Primobolan, Masteron, or Testosterone Propionate.

Female Dosage (Advanced Users Only):

• 5–10 mg/day for up to 4–6 weeks

⚠️ Monitor for signs of virilization; discontinue if side effects appear

• Medical Use (Under Supervision):

• Anemia / Angioedema: Dosage as prescribed by a licensed physician

• Side Effects & Warnings

Potential Side Effects:

• Hepatotoxicity (due to 17α-alkylated oral form)
• Alterations in cholesterol levels (↓ HDL, ↑ LDL)
• Mild androgenic effects (acne, hair loss, voice deepening in women)
• Joint dryness (due to lack of water retention)
• Natural testosterone suppression (especially at higher doses)

Precautions:

• Always use liver protection (TUDCA, NAC)
• Avoid long cycles to reduce liver strain
• Perform regular bloodwork during use
• Include Post Cycle Therapy (PCT) after cessation
• Not recommended for individuals with pre-existing liver, kidney, or heart conditions

• Regulatory Disclaimer

VIRILOZOL (Stanozolol USP) is a controlled anabolic agent and must be used only where legally permitted under medical or professional supervision. Unauthorized use can pose serious health risks and may be subject to legal restrictions. Always consult a licensed health practitioner prior to use.

.

Dosage

Dose
Duration